Stroke:药物相关性卒中

2021-11-21 “脑血管病及重症文献导读”公众号 “脑血管病及重症文献导读”公众号

某些药物可能会增加缺血性卒中(ischemic stroke,IS)的风险。2021年10月来自葡萄牙的Jo?o Pedro Marto等在 Stroke 上发表了主题综述《药物相关性缺血性卒中》。该

某些药物可能会增加缺血性卒中(ischemic stroke,IS)的风险。2021年10月来自葡萄牙的Jo?o Pedro Marto等在 Stroke 上发表了主题综述《药物相关性缺血性卒中》。该综述目的在于探索常用药物和IS之间的联系。

关联的证据级别定义为,A(高级别的关联证据)到E(高级别的无关联证据)。高级别关联的药物包括,促红细胞生成素、联合避孕剂、口服雌激素替代疗法、贝伐单抗、他莫昔芬、抗精神病药物;中等级别关联的药物包括,帕纳替尼、尼洛替尼、达芦那韦和促性腺激素释放激素激动剂。

图一、缺血性卒中和药物相关的证据水平:

图二、根据解剖治疗化学分类,总结药物与IS之间的关联,以及可能的关联机制:

原始出处:

Joo Pedro Marto, et al. Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke.2021 Oct;52(10):e646-e659. doi: 10.1161/STROKEAHA.120.033272. Epub 2021 Aug 18.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1838009, encodeId=a97a1838009db, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Feb 28 03:02:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073543, encodeId=f4e710e3543f2, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b61b5631784, createdName=ms6000002052166013, createdTime=Wed Nov 24 15:24:36 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073483, encodeId=35c010e34831e, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98e15470025, createdName=ms7000001163334588, createdTime=Wed Nov 24 11:02:39 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1838009, encodeId=a97a1838009db, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Feb 28 03:02:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073543, encodeId=f4e710e3543f2, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b61b5631784, createdName=ms6000002052166013, createdTime=Wed Nov 24 15:24:36 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073483, encodeId=35c010e34831e, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98e15470025, createdName=ms7000001163334588, createdTime=Wed Nov 24 11:02:39 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-11-24 ms6000002052166013

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1838009, encodeId=a97a1838009db, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Feb 28 03:02:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073543, encodeId=f4e710e3543f2, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b61b5631784, createdName=ms6000002052166013, createdTime=Wed Nov 24 15:24:36 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073483, encodeId=35c010e34831e, content=积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98e15470025, createdName=ms7000001163334588, createdTime=Wed Nov 24 11:02:39 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-11-24 ms7000001163334588

    积分

    0

相关资讯

JAHA:血清非酯化脂肪酸与卒中事件的关系

该研究发现总共有2个NEFA亚类和3个单独的NEFA与卒中发生相关。其中,NEFAn-3亚类和二高-γ-亚麻酸来源于饮食,可能是总体卒中风险的潜在生物标志物。

冬季卒中高发!记住救命口诀,关键时刻不后悔!

人在冬天对外界环境变化的适应性、应激性和抵抗力降低,极易导致脑卒中。

Neurology:误诊为神经白塞病的反复脑干卒中

大约一半的DADA2患者存在不同程度不同类型的血液学和免疫学异常。实验室研究可能显示多系细胞减少,包括淋巴细胞减少、中性粒细胞减少、贫血、和血小板减少症。儿童早发卒中并且存在全身血管病变者,应该考虑D

心电图or颅脑MRA?更能找出预后不良的癌症合并卒中患者?

PLOS ONE:颅内动脉粥样硬化和心房颤动对活动性癌症患者缺血性中风的预后的影响

2021美国心脏协会年会:使用可穿戴设备或能检测房颤

这项近50万可穿戴设备的人群研究中,含有新型Fitbit软件算法的可穿戴设备中在检测房颤方面有较高的预测价值,可能有助于识别未诊断出的新房颤患者

Stroke:卒中后长期认知能力下降

卒中患者在发病后1至3年内出现认知衰退,其下降速度比无卒中对照者更快。下降率的加快与老年和复发性卒中相关。